The Celonic Group is a fast rising, mid-sized biologics CDMO focusing uniquely on mammalian expressed drugs. It provides end to end drug substance development and manufacturing solutions for monoclonal antibodies, bispecifics and other complex molecules from development all the way to commercial supply. Celonic combines the expertise like larger CDMOs with the agility and a collaboration mindset of a family owned business. The Celonic Group is privately-owned and part of the independent German family business J. Rettenmaier & Söhne Group (JRS). Celonic’s history is a success story. Over 30 years, the company has continuously expanded from…